Do no harm: Not even to some degree

Journal of Clinical Sleep Medicine

Volumn 8, Issue 4, 2012, Pages 353-354

  Kripke, Daniel F ^a   Langer, Robert D ^b   Kline, Lawrence E ^a  

^a SCRIPPS CLINIC   (United States)

^b Jackson Hole Center for Preventive Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; TRANQUILIZER; ZOLPIDEM;

AGE; CANCER INCIDENCE; COMORBIDITY; CORRELATION ANALYSIS; DEPRESSION; EDITORIAL; FOLLOW UP; GENDER; HUMAN; INSOMNIA; MORTALITY; NEOPLASM; NERVE CELL PLASTICITY; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SLEEP DISORDER; SLEEP DISORDERED BREATHING; SMOKING;

EID: 84866761058     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.2018     Document Type: Editorial

References (6)

1. Kripke DF, Langer RD, Kline LE. Hypnotics' association with mortality or cancer: a matched cohort study. BMJ Open 2012;2:e000850.
2. Kao CH, Sun LM, Liang JA, Chang SN, Sung FC, Muo CH. Relationship of zolpidem and cancer risk: a Taiwanese population-based cohort study. Mayo Clin Proc 2012;87:430-6.
3. Belleville G. Mortality hazard associated with anxiolytic and hypnotic drug use in the national population health survey. Can J Psychiatry 2010;55:137-46.
4. Patten SB, Williams JV, Lavorato D, Li WJ, Khaled S, Bulloch AG. Mortality associated with major depression in a Canadian community cohort. Can J Psychiatry 2011;56:658-66.
5. Young T, Finn L, Peppard PE, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008;31:1071-8.
6. Punjabi NM, Caffo BS, Goodwin JL, et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009;6:e1000132.